As mentioned in our last report, Gritstone Bio (GRTS) initially applied its next-generation heterologous (virus/sa-mRNA) vaccine technology to fight cancer. The thesis articulated by the founding … [Read more...] about Gritstone Bio (GRTS) Makes History in a Historically Hopeless Setting
Embarrassment of T Cell Riches
GRTS: Embarrassment of T Cell Riches It’s estimated that 90% of retail investors lose money. We help you beat those odds with concise research, education and more. Click here to see our … [Read more...] about Embarrassment of T Cell Riches
Daily Trade Insights
La Jolla Pharmaceuticals (Nasdaq: LJPC) Swing Move
Trade Summary Ticker: LJPC (Last 12/26/19: $4.05) Entry: $4.0-5.0 Price Target: $7.96-20 Target Time-frame: 0-8 weeks Trade ThesisAs of 12/25/19, a disconnect remains … [Read more...] about La Jolla Pharmaceuticals (Nasdaq: LJPC) Swing Move
DelMar Pharmaceuticals (Nasdaq: DMPI) Approaches a Key Inflection Point At the 2019 Society for Neuro-Oncology Annual Meeting
In my last article I summarized my discussions with DelMar Pharmaceuticals’ (Nasdaq: DMPI) President and CEO Saiid Zarrabian and the value proposition DelMar offers investors. To recap, DelMar … [Read more...] about DelMar Pharmaceuticals (Nasdaq: DMPI) Approaches a Key Inflection Point At the 2019 Society for Neuro-Oncology Annual Meeting
ChemoCentryx Inc Trade Idea
Trade Summary Ticker: CCXI (Last: $8.84) Entry: $8.50-8.84 Price Target: $13-15.0+ Target Timeframe: 0-6 weeks Trade ThesisCCXI is an orphan/rare disease-focused company with … [Read more...] about ChemoCentryx Inc Trade Idea
NG-mother-effin-M
Trade Summary Ticker: NGM (Last: $13.01) Entry: $12.70-13.0 Price Target: $14.50-20.00 Target Time-frame: 1-8 weeks Source: Trading View Trade Thesis NGM recovered as I … [Read more...] about NG-mother-effin-M
Introducing the New and Improved DelMar Pharmaceuticals (Nasdaq: DMPI)
On September 25th, 2019 the MS Money Moves Executive Leadership Team had an hour long conference call with President and CEO of DelMar Pharmaceuticals (Nasdaq: DMPI) Saiid Zarrabian and acting Chief … [Read more...] about Introducing the New and Improved DelMar Pharmaceuticals (Nasdaq: DMPI)
Trade-Ideas for Monday, August 12th, 2019
Trade-Ideas: Thursday, Monday, August 12th, 2019Trade ideas for next week:1) BDSI $4.36* Continuation swing opportunity.* Gained 16% last week.* Released strong earnings last week with strong revenue … [Read more...] about Trade-Ideas for Monday, August 12th, 2019
Biopharma Stock Watch July 29th-August 2nd
Source: MS Money Moves Stocks closed higher last week in anticipation of the Fed to cut interest rates for the first time since the 2008 financial crisis. While this is welcomed by investors we … [Read more...] about Biopharma Stock Watch July 29th-August 2nd
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish
You must be logged in to post a comment.